MyChart Login
Clinical Trials
Career Opportunities
Contact Us

Home › Clinical Trials › Cancer Clinical Trial › Breast › Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using Diffuse Optical Spectroscopic Imaging in a Multi-Center Setting

Print
A A A

Important information about COVID-19 ›

Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using Diffuse Optical Spectroscopic Imaging in a Multi-Center Setting

Protocol Number: UCI-15-83

NCT Number: NCT02725658

Condition/Disease: Cancer - Breast

Principal Investigator: Bruce Tromberg

Status: Open

Treatment: Diagnostic

Phase: NA

Age Group: Adult

Scope: National

Learn More:
For information about cancer clinical trials at the UCI Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.